ANL · Nasdaq · CIK 0001944552

Adlai Nortye Group Ltd.

Adlai Nortye Group Ltd.’s most recent SEC filing in our snapshot is a Form 6-K filed on Oct 15, 2026. Its EDGAR record lists 5 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2024

—

Net income, FY2024

-$51.9M

Form 4 filings on record, past 12 months

Company overview

Legal name (as filed): Adlai Nortye Group Ltd.
Ticker: ANL
SEC Central Index Key (CIK): 0001944552
Industry (SIC): Pharmaceutical Preparations (code 2834)
Business address: SINGAPORE
State or country of incorporation: DE
Fiscal year ends: December 31
SEC filer category: Non-accelerated filer<br>Emerging growth company
Position in SEC ticker list: #2682 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Adlai Nortye Group Ltd.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue

Net income

ANL annual results
Item	FY2021 ended Dec 31, 2021	FY2022 ended Dec 31, 2022	FY2023 ended Dec 31, 2023	FY2024 ended Dec 31, 2024
Revenue	$45.7M	—	$5.0M	—
Net income	-$56.7M	-$58.8M	-$109.2M	-$51.9M
Diluted EPS	-$2.23	-$2.31	-$2.52	-$0.54
Total assets	—	$72.6M	$130.2M	$71.3M
Cash and equivalents	$64.1M	$42.8M	$91.5M	$60.9M

XBRL tags used: revenue = Revenue; netIncome = ProfitLoss; assets = Assets; eps = DilutedEarningsLossPerShare; cash = CashAndCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

ANL latest annual, quarterly, current and proxy reports
Filed	Form	What it is	Original
Apr 10, 2026	20-F	ANNUAL REPORT· period Dec 31, 2025	Document · Index
Oct 15, 2026	6-K	REPORT OF FOREIGN PRIVATE ISSUER· period Oct 15, 2026	Document · Index

Recent SEC filings

The 40 newest documents filed by or about Adlai Nortye Group Ltd., by form type:

6-K ×103 ×84 ×5SCHEDULE 13G/A ×3EFFECT ×2S-8 POS ×23/A ×2F-3/A ×2144 ×1POS AM ×1424B7 ×1SCHEDULE 13G ×1CORRESP ×120-F ×1

ANL recent filings
Filed	Form	What it is	Original
Oct 15, 2026	6-K	REPORT OF FOREIGN PRIVATE ISSUER· period Oct 15, 2026	Document · Index
Oct 1, 2026	4	Statement of changes in beneficial ownership (insider trade)· period Sep 29, 2026	Document · Index
Sep 30, 2026	6-K	REPORT OF FOREIGN PRIVATE ISSUER· period Sep 30, 2026	Document · Index
Sep 30, 2026	6-K	REPORT OF FOREIGN PRIVATE ISSUER· period Sep 30, 2026	Document · Index
Sep 24, 2026	4	Statement of changes in beneficial ownership (insider trade)· period Sep 22, 2026	Document · Index
Sep 18, 2026	144	Notice of proposed sale of securities	Document · Index
Sep 15, 2026	EFFECT	EFFECT	Document · Index
Sep 11, 2026	S-8 POS	REGISTRATION STATEMENT	Document · Index
Sep 11, 2026	S-8 POS	REGISTRATION STATEMENT	Document · Index
Sep 11, 2026	POS AM	POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3	Document · Index
Sep 8, 2026	6-K	REPORT OF FOREIGN PRIVATE ISSUER· period Sep 8, 2026	Document · Index
Aug 26, 2026	4	Statement of changes in beneficial ownership (insider trade)· period Aug 24, 2026	Document · Index
Aug 26, 2026	6-K	CURRENT REPORT· period Aug 26, 2026	Document · Index
Aug 19, 2026	6-K	REPORT OF FOREIGN PRIVATE ISSUER· period Aug 19, 2026	Document · Index
Aug 14, 2026	SCHEDULE 13G/A	Passive beneficial ownership report (over 5%)	Document · Index
Aug 14, 2026	6-K	REPORT OF FOREIGN PRIVATE ISSUER· period Aug 14, 2026	Document · Index
Aug 14, 2026	SCHEDULE 13G/A	Passive beneficial ownership report (over 5%)	Document · Index
Aug 4, 2026	3	Initial statement of beneficial ownership· period Mar 18, 2026	Document · Index
Aug 3, 2026	6-K	REPORT OF FOREIGN PRIVATE ISSUER· period Aug 3, 2026	Document · Index
Jul 20, 2026	424B7	PROSPECTUS SUPPLEMENT	Document · Index
Jul 17, 2026	6-K	REPORT OF FOREIGN PRIVATE ISSUER· period Jul 16, 2026	Document · Index
Jul 15, 2026	3	Initial statement of beneficial ownership· period Mar 18, 2026	Document · Index
Jun 10, 2026	4	Statement of changes in beneficial ownership (insider trade)· period Dec 16, 2018	Document · Index
Jun 1, 2026	3	Initial statement of beneficial ownership· period May 28, 2026	Document · Index
May 28, 2026	3	Initial statement of beneficial ownership· period Mar 18, 2026	Document · Index
May 21, 2026	4	Statement of changes in beneficial ownership (insider trade)· period Mar 18, 2026	Document · Index
May 21, 2026	3	Initial statement of beneficial ownership· period Mar 18, 2026	Document · Index
May 20, 2026	3	Initial statement of beneficial ownership· period Mar 18, 2026	Document · Index
May 15, 2026	SCHEDULE 13G	Passive beneficial ownership report (over 5%)	Document · Index
May 14, 2026	3/A	Initial statement of beneficial ownership· period Mar 18, 2026	Document · Index
May 14, 2026	SCHEDULE 13G/A	Passive beneficial ownership report (over 5%)	Document · Index
May 8, 2026	3	Initial statement of beneficial ownership· period Mar 18, 2026	Document · Index
May 8, 2026	3/A	Initial statement of beneficial ownership· period Mar 18, 2026	Document · Index
Apr 29, 2026	3	Initial statement of beneficial ownership· period Mar 18, 2026	Document · Index
Apr 28, 2026	EFFECT	EFFECT	Document · Index
Apr 24, 2026	CORRESP	CORRESP	Document · Index
Apr 24, 2026	F-3/A	AMENDMENT NO. 2 TO FORM F-3	Document · Index
Apr 23, 2026	F-3/A	AMENDMENT NO. 1 TO FORM F-3	Document · Index
Apr 16, 2026	6-K	REPORT OF FOREIGN PRIVATE ISSUER· period Apr 16, 2026	Document · Index
Apr 10, 2026	20-F	ANNUAL REPORT· period Dec 31, 2025	Document · Index

Insider filing activity

5 Form 4 filings appear in Adlai Nortye Group Ltd.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Pharmaceutical Preparations

All 194 companies in Pharmaceutical Preparations

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001944552 and XBRL company facts. Adlai Nortye Group Ltd. on EDGAR.
Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.